Detalles de la búsqueda
1.
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK.
Proc Natl Acad Sci U S A;
112(9): E966-72, 2015 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25730880
2.
B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.
Blood;
123(10): 1512-5, 2014 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24449209
3.
A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity.
Proc Natl Acad Sci U S A;
109(36): 14526-31, 2012 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22875703
4.
Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphoma.
Protein Expr Purif;
75(1): 15-20, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20851769
5.
Cell-free production of Gaussia princeps luciferase--antibody fragment bioconjugates for ex vivo detection of tumor cells.
Biochem Biophys Res Commun;
390(3): 971-6, 2009 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-19852937
6.
Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.
Mol Cancer Ther;
6(11): 2995-3008, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18025284
7.
A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery.
Biomol Eng;
21(6): 145-55, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15748688
8.
Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors.
Vaccine;
24(3): 304-16, 2006 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-16125282
9.
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
Blood;
108(8): 2745-54, 2006 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16804109
10.
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.
Proc Natl Acad Sci U S A;
99(16): 10706-11, 2002 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-12149472
Resultados
1 -
10
de 10
1
Próxima >
>>